Journal of Clinical Psychology in Medical Settings

, Volume 16, Issue 3, pp 243–253 | Cite as

Telephone-Administered Cognitive Behavioral Therapy: A Case Study of Anxiety and Depression in Parkinson’s Disease

  • Connie Veazey
  • Karon F. Cook
  • Melinda Stanley
  • Eugene C. Lai
  • Mark E. Kunik


Parkinson’s disease (PD) is a chronic medical illness with a high incidence of psychiatric comorbidity, specifically depression and anxiety. Research on treatment of such psychiatric complications is scarce. Non-pharmaceutical treatment options are especially attractive. Cognitive behavioral therapy (CBT) is a psychotherapeutic treatment option that has been successful in other chronically medically ill populations with comorbid depression and anxiety. The current research had two aims. The first was to pilot the feasibility of screening and identifying PD patients with symptoms of anxiety and depression in a specialized outpatient clinic. The second aim was to pilot the feasibility of telephone-administered CBT for the treatment of depression and anxiety in persons with PD, which was done through a case series comparing telephone-administered CBT to a Support strategy. A fairly large portion (67.5%) of patients screened in the outpatient clinic were identified as having symptoms of anxiety and/or depression. Results also indicated that CBT delivered via the telephone is a useful approach for targeting psychiatric symptoms in this population. A case example is given to illustrate the clinical considerations associated with delivering therapy via telephone to persons with PD.


Cognitive behavioral therapy Parkinson’s disease Anxiety Depression Chronic illness 



This work was supported in part by the Houston VA HSR&D Center of Excellence (Houston Center for Quality of Care & Utilization Studies; HFP-90-020).


  1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
  2. Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory: Manual. San Antonio, TX: The Psychological Corporation: Harcourt Brace & Company.Google Scholar
  3. Beiske, A. G., Svennsson, E., Sandanger, I., Czujko, B., Pederson, E. D., Aarseth, J. H., et al. (2008). Depression and anxiety amongst multiple sclerosis patients. European Journal of Neurology, 15, 239–245. doi: 10.1111/j.1468-1331.2007.02041.x.PubMedCrossRefGoogle Scholar
  4. Bilich, L. L., Deane, F. P., Phipps, A. B., Barisic, M., & Gould, G. (2008). Effectiveness of bibliotherapy self-help for depression with varying levels of telephone helpline support. Clinical Psychology and Psychotherapy, 15, 61–74. doi: 10.1002/cpp.562.PubMedCrossRefGoogle Scholar
  5. Cantello, R., Aguggia, M., Gilli, M., Delsedime, M., Chiardo-Cutin, I., Riccio, A., et al. (1989). Major depression in Parkinson’s disease and the mood response to intravenous methylphenidate: Possible role of the ‘hedonic’ dopamine synapse. Journal of Neurology, Neurosurgery and Psychiatry, 52, 724–731. doi: 10.1136/jnnp.52.6.724.CrossRefGoogle Scholar
  6. Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716. doi: 10.1146/annurev.psych.52.1.685.PubMedCrossRefGoogle Scholar
  7. Crum, R. M., Anthony, J. C., Bassett, S. S., & Folstein, M. F. (1993). Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA, 269, 2386–2391. doi: 10.1001/jama.269.18.2386.PubMedCrossRefGoogle Scholar
  8. Cubo, E., Bernard, B., Leurgans, S., & Raman, R. (2000). Cognitive and motor function in patients with Parkinson’s disease with and without depression. Clinical Neuropharmacology, 23, 331–334. doi: 10.1097/00002826-200011000-00006.PubMedCrossRefGoogle Scholar
  9. Cummings, J. L., & Masterman, D. L. (1999). Depression in patients with Parkinson’s disease. International Journal of Geriatric Psychiatry, 14, 711–718. doi: 10.1002/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1.PubMedCrossRefGoogle Scholar
  10. Dbouk, N., Arguedas, M. R., & Sheikh, A. (2008). Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C. Digestive Diseases and Sciences, 53, 1100–1106. doi: 10.1007/s10620-007-9985-z.PubMedCrossRefGoogle Scholar
  11. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. (1996). Structured Clinical Interview for DSM-IV Axis-I Disorders: Patient edition (with psychotic screen) (SCID-I/P (with psychotic screen)) (Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.Google Scholar
  12. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. doi: 10.1016/0022-3956(75)90026-6.PubMedCrossRefGoogle Scholar
  13. Gorenstein, E. E., Papp, L. A., & Kleber, M. S. (1999). Cognitive behavioral treatment of anxiety in later life. Cognitive and Behavioral Practice, 6, 305–320. doi: 10.1016/S1077-7229(99)80050-9.CrossRefGoogle Scholar
  14. Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score. Age and Ageing, 26, 353–357. doi: 10.1093/ageing/26.5.353.PubMedCrossRefGoogle Scholar
  15. Kabacoff, R. I., Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1997). Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and the State-Trait Anxiety Inventory with older adult psychiatric outpatients. Journal of Anxiety Disorders, 11, 33–47. doi: 10.1016/S0887-6185(96)00033-3.PubMedCrossRefGoogle Scholar
  16. Keppel, G. (1991). Design and analysis: A researcher’s handbook (3rd ed.). Englewood Cliffs, NJ: Prentice-Hall, Inc.Google Scholar
  17. Kroenke, K., Jackson, J. L., & Chamberlin, J. (1997). Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors of outcome. American Journal of Medicine, 103, 339–347. doi: 10.1016/S0002-9343(97)00241-6.PubMedCrossRefGoogle Scholar
  18. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.PubMedCrossRefGoogle Scholar
  19. Kroenke, K., Spitzer, R. L., Williams, J. B., Linzer, M., Hahn, S. R., DeGruy, F. V., et al. (1994). Physical symptoms in primary care: Predictors of psychiatric disorders and functional impairment. Archives of Family Medicine, 3, 774–779. doi: 10.1001/archfami.3.9.774.PubMedCrossRefGoogle Scholar
  20. Kunik, M. E., Azzam, P. N., Souchek, J., Cully, J. A., Wray, N. P., Krishnan, L. L., et al. (2007). A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics, 48, 16–21. doi: 10.1176/appi.psy.48.1.16.PubMedCrossRefGoogle Scholar
  21. Kunik, M. E., Braun, U., Stanley, M. A., Wristers, K., Molinari, V., Stoebner, D., et al. (2001). One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychological Medicine, 31, 717–723. doi: 10.1017/S0033291701003890.PubMedCrossRefGoogle Scholar
  22. Kunik, M. E., Veazey, C., Cully, J. A., Souchek, J., Graham, D. P., Hopko, D., et al. (2008). COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychological Medicine, 38, 385–396. doi: 10.1017/S0033291707001687.PubMedCrossRefGoogle Scholar
  23. Lenze, E. J., Mulsant, B. H., Shear, M. K., Houck, P., & Reynolds, C. F. (2002). Anxiety symptoms in elderly patient with depression: What is the best approach to treatment. Drugs and Aging, 19, 753–760. doi: 10.2165/00002512-200219100-00004.PubMedCrossRefGoogle Scholar
  24. Lenze, E. J., Mulsant, B. H., Shear, M. K., Schulberg, H. C., Dew, M. A., Begley, A. E., et al. (2000). Comorbid anxiety disorders in depressed elderly patients. American Journal of Psychiatry, 157, 722–728. doi: 10.1176/appi.ajp.157.5.722.PubMedCrossRefGoogle Scholar
  25. Leo, R. J. (1996). Movement disorders associated with the serotonin selective reuptake inhibitors. Journal of Clinical Psychiatry, 57, 449–454.PubMedGoogle Scholar
  26. Ludman, E., Simon, G. E., Tutty, S., & Von Korff, M. (2007). A randomized trial of telephone psychotherapy and pharmacotherapy for depression: Continuation and durability of effects. Journal of Consulting and Clinical Psychology, 75, 257–266. doi: 10.1037/0022-006X.75.2.257.PubMedCrossRefGoogle Scholar
  27. Meara, J., Mitchelmore, E., & Hobson, H. (1999). Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age and Ageing, 28, 35–38. doi: 10.1093/ageing/28.1.35.PubMedCrossRefGoogle Scholar
  28. Menza, M. A., Robertson-Hoffman, D. E., & Bonapace, A. S. (1993). Parkinson’s disease and anxiety: Comorbidity with depression. Biological Psychiatry, 34, 465–470. doi: 10.1016/0006-3223(93)90237-8.PubMedCrossRefGoogle Scholar
  29. Mohr, D. C., Hart, S., Julian, L., Catledge, C., Honos-Webb, L., Vella, L., et al. (2005). Telephone-administered psychotherapy for depression. Archives of General Psychiatry, 62, 1007–1014. doi: 10.1001/archpsyc.62.9.1007.PubMedCrossRefGoogle Scholar
  30. Mohr, D. C., Lokosky, W., Bertagnoli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., et al. (2000). Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Journal of Consulting and Clinical Psychology, 68, 356–361. doi: 10.1037/0022-006X.68.2.356.PubMedCrossRefGoogle Scholar
  31. Morin, C. M., Landreville, P., Colecchi, C., McDonald, K., Stone, J., & Ling, W. (1999). The Beck Anxiety Inventory: Psychometric properties with older adults. Journal of Clinical Geropsychology, 5, 19–29. doi: 10.1023/A:1022986728576.CrossRefGoogle Scholar
  32. Murray, J. B. (1996). Depression in Parkinson’s disease. Journal of Psychology, 130, 659–667.PubMedGoogle Scholar
  33. Oehlberg, K., Barg, F. K., Brown, G. K., Taraborelli, D., Stern, M. B., & Weintraub, D. (2008). Attitudes regarding the etiology and treatment of depression in Parkinson’s disease: A qualitative study. Journal of Geriatric Psychiatry and Neurology, 21, 123–132. doi: 10.1177/0891988708316862.PubMedCrossRefGoogle Scholar
  34. Oertel, W. H., Hoglinger, G. U., Caraceni, T., Girotti, F., Eichhorn, T., Spottke, A. E., et al. (2001). Depression in Parkinson’s disease: An update. Advances in Neurology, 86, 373–383.PubMedGoogle Scholar
  35. Peto, V., Jenkinson, C., & Fitzpatrick, R. (1998). PDQ-39: A review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. Journal of Neurology, 245(Suppl 1), S10–S14. doi: 10.1007/PL00007730.PubMedCrossRefGoogle Scholar
  36. Roundy, K., Cully, J. A., Stanley, M. A., Veazey, C., Souchek, J., Wray, N. P., et al. (2005). Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review. Primary Care Companion to the Journal of Clinical Psychiatry, 7, 213–218.PubMedGoogle Scholar
  37. Sherbourne, C. D., Jackson, C. A., Meredith, L. A., Camp, P., & Wells, K. (1996). Prevalence of comorbid anxiety disorders in primary care outpatients. Archives of Family Medicine, 5, 27–35. doi: 10.1001/archfami.5.1.27.PubMedCrossRefGoogle Scholar
  38. Sherbourne, C. D., & Wells, K. (1997). Course of depression in patients with comorbid anxiety disorders. Journal of Affective Disorders, 43, 245–250. doi: 10.1016/S0165-0327(97)01442-0.PubMedCrossRefGoogle Scholar
  39. Slaughter, J. R., Slaughter, K. A., Nichols, D., Holmes, S. E., & Martens, M. P. (2001). Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 187–196. doi: 10.1176/appi.neuropsych.13.2.187.PubMedGoogle Scholar
  40. Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA, 282, 1737–1744. doi: 10.1001/jama.282.18.1737.PubMedCrossRefGoogle Scholar
  41. Stanley, M. A., Beck, J. G., Novy, D. M., Averill, P. M., Swann, A. C., Diefenbach, G. J., et al. (2003). Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 71, 309–319. doi: 10.1037/0022-006X.71.2.309.PubMedCrossRefGoogle Scholar
  42. Stanley, M. A., Diefenbach, G. J., & Hopko, D. R. (2004). Cognitive behavioral treatment for older adults with generalized anxiety disorder. A therapist manual for primary care settings. Behavior Modification, 28, 73–117. doi: 10.1177/0145445503259259.PubMedCrossRefGoogle Scholar
  43. Stanley, M. A., Veazey, C., Hopko, D., Diefenbach, G., & Kunik, M. E. (2005). Anxiety and depression in chronic obstructive pulmonary disease (COPD): A new intervention and case report. Cognitive and Behavioral Practice, 12, 424–436. doi: 10.1016/S1077-7229(05)80070-7.CrossRefGoogle Scholar
  44. Steer, R. A., Willman, M., Kay, P. A. J., & Beck, A. T. (1994). Differentiating elderly medical and psychiatric outpatients with the Beck Anxiety Inventory. Assessment, 1, 345–351.Google Scholar
  45. Veazey, C., Aki, S. O. E., Cook, K. F., Lai, E., & Kunik, M. E. (2005). Prevalence and treatment of depression in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 310–323. doi: 10.1176/appi.neuropsych.17.3.310.PubMedGoogle Scholar
  46. Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2003). Recognition and treatment of depression in Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology, 16, 178–183. doi: 10.1177/0891988703256053.PubMedCrossRefGoogle Scholar
  47. Wetherell, J. L., & Arean, P. A. (1997). Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Psychological Assessment, 9, 136–144. doi: 10.1037/1040-3590.9.2.136.CrossRefGoogle Scholar
  48. Yeh, A. H., Taylor, S., Thordarson, D. S., & Corcoran, K. M. (2003). Efficacy of telephone-administered cognitive behaviour therapy for obsessive-compulsive spectrum disorders: Case studies. Cognitive Behaviour Therapy, 32, 75–81. doi: 10.1080/16506070302323.PubMedCrossRefGoogle Scholar
  49. Zung, W. K., Magruder-Habib, K., Velez, R., & Alling, W. (1990). The comorbidity of anxiety and depression in general medical patients: A longitudinal study. Journal of Clinical Psychiatry, 51, 77–80.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Connie Veazey
    • 1
  • Karon F. Cook
    • 2
  • Melinda Stanley
    • 3
    • 4
    • 5
    • 6
  • Eugene C. Lai
    • 4
    • 7
    • 8
  • Mark E. Kunik
    • 3
    • 4
    • 5
    • 6
    • 9
  1. 1.Department of PsychologyUniversity of Louisiana at LafayetteLafayetteUSA
  2. 2.Department of Rehabilitation MedicineUniversity of WashingtonSeattleUSA
  3. 3.Houston Center for Quality of Care and Utilization StudiesHealth Services Research and Development ServiceHoustonUSA
  4. 4.Michael E. DeBakey Veterans Affairs Medical CenterHoustonUSA
  5. 5.Menninger Department of Psychiatry and Behavioral SciencesBaylor College of MedicineHoustonUSA
  6. 6.Veterans Affairs South Central Mental Illness Research, Education, & Clinical CenterHoustonUSA
  7. 7.Department of NeurologyBaylor College of MedicineHoustonUSA
  8. 8.Houston VA Parkinson’s Disease Research, Education, & Clinical CenterHoustonUSA
  9. 9.Department of MedicineBaylor College of MedicineHoustonUSA

Personalised recommendations